LABORATORY CORP OF AMERICA HOLDINGS
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
LH$371.83+1.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Shareholders' Equity
Index
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
| CommonStock | AdditionalPaid-inCapital | RetainedEarnings | AccumulatedOtherComprehensiveEarnings (Loss) | TotalShareholders’Equity | |
|---|---|---|---|---|---|
| BALANCE AT DECEMBER 31, 2020 | $9.0 | $110.3 | $9,479.2 | $(161.9) | $9,436.6 |
| Net earnings attributable to Laboratory Corporation of America Holdings | — | — | 2,377.3 | — | 2,377.3 |
| Other comprehensive earnings (loss), net of tax | — | — | — | (30.0) | (30.0) |
| Issuance of common stock under employee stock plans | — | 51.7 | — | — | 51.7 |
| Net share settlement tax payments from issuance of stock to employees | — | (47.4) | — | — | (47.4) |
| Stock compensation | — | 153.7 | — | — | 153.7 |
| Purchase of common stock | (0.5) | (268.3) | (1,399.7) | — | (1,668.5) |
| BALANCE AT DECEMBER 31, 2021 | 8.5 | — | 10,456.8 | (191.9) | 10,273.4 |
| Net earnings attributable to Laboratory Corporation of America Holdings | — | — | 1,279.1 | — | 1,279.1 |
| Other comprehensive earnings (loss), net of tax | — | — | — | (301.3) | (301.3) |
| Dividends declared | — | — | (198.7) | — | (198.7) |
| Issuance of common stock under employee stock plans | — | 50.6 | — | — | 50.6 |
| Net share settlement tax payments from issuance of stock to employees | — | (50.6) | — | — | (50.6) |
| Stock compensation | — | 144.1 | — | — | 144.1 |
| Purchase of common stock | (0.4) | (144.1) | (955.5) | — | (1,100.0) |
| BALANCE AT DECEMBER 31, 2022 | 8.1 | — | 10,581.7 | (493.2) | 10,096.6 |
| Net earnings attributable to Laboratory Corporation of America Holdings | — | — | 418.0 | — | 418.0 |
| Other comprehensive earnings (loss), net of tax | — | — | — | 195.9 | 195.9 |
| Fortrea Holdings Inc. spin-off | — | — | (1,970.0) | 238.0 | (1,732.0) |
| Dividends declared | — | — | (256.1) | — | (256.1) |
| Issuance of common stock under employee stock plan | — | 55.2 | — | — | 55.2 |
| Net share settlement tax payments from issuance of stock to employees | — | (40.9) | — | — | (40.9) |
| Stock compensation | — | 147.3 | — | — | 147.3 |
| Purchase of common stock | (0.4) | (123.2) | (885.4) | — | (1,009.0) |
| BALANCE AT DECEMBER 31, 2023 | $7.7 | $38.4 | $7,888.2 | $(59.3) | $7,875.0 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.